Cell-free DNA may be key to monitoring urinary tract infections

A new method for testing urinary tract infections yields more information than what conventional methods can offer, according to new research.

‘Cornell AgriTech’ reflects influence in food, ag innovation

The College of Agriculture and Life Sciences announced Aug. 1 the renaming of the New York State Agricultural Experiment Station to Cornell AgriTech.

Community-based Seed System Initiative thrives in Nepal

The Seed System Initiative, implemented by Cornell’s Delivering Genetic Gain in Wheat project in 2017-18, benefits wheat farmers in Nepal.

Study reveals how promising cancer drug works for best use

A study describes for the first time how a promising FDA-approved cancer drug – currently in clinical trials – works to effectively kill cancer cells. 

Immunology symposium unites Ithaca, New York City scientists

Cornell experts from Ithaca and New York City gathered June 26-27 at the College of Veterinary Medicine for the Immunology in Health and Disease Symposium.

Atkinson's Academic Venture Fund awards $1.5M to 12 projects

The Atkinson Center for a Sustainable Future’s Academic Venture Fund has awarded $1.5 million to a range of projects that will provide sustainable solutions around the world, from the Finger Lakes to the Pamir Mountains in Central Asia.

Scholars train for research in real-world settings

Thirty-three researchers from across the globe visited the Bronfenbrenner Center for Translational Research last month to learn how to conduct research through community partnerships that will inform real-world practices and decisions.

Lab-grown tumors provide insights on rare prostate cancer

Growing miniature tumors from a patient’s cells in the laboratory may help scientists personalize treatments for those with a rare form of prostate cancer, according a study by Weill Cornell Medicine and NewYork-Presbyterian scientists.

Low-carb, high-fat diet may boost targeted cancer therapy

A very low carbohydrate, high-fat diet called the ketogenic diet may improve the effectiveness of an emerging class of cancer drugs, according to a new study.